|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acromegaly | |||||
| 2 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Endocrine | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Endocrine System Diseases | |||||
| Hyperpituitarism | |||||
| Hypothalamic Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Pituitary Diseases | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Growth Hormone-Releasing Hormone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 5 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| University of Michigan | |||||